Abstract:Epigenetic 'reader' proteins, which have evolved to interact with specific chromatin modifications, play pivotal roles in gene regulation. There is growing interest in the alternative splicing mechanisms that affect the functionality of such epigenetic readers in cancer etiology. The current review considers how deregulation of epigenetic processes and alternative splicing events contribute to pathophysiology. An A–Z guide of epigenetic readers is provided, delineating the antagonistic 'yin-yang' roles of full-length versus spliced isoforms, where this is known from the literature. The examples discussed underscore the key contributions of epigenetic readers in transcriptional regulation, early development, and cancer. Clinical implications are considered, offering insights into precision oncology and targeted therapies focused on epigenetic readers that have undergone alternative splicing events during disease pathogenesis. This review underscores the fundamental importance of alternative splicing events in the context of epigenetic readers while emphasizing the critical need for improved understanding of functional diversity, regulatory mechanisms, and future therapeutic potential.

What problem does this paper attempt to address?

The paper primarily explores the role of epigenetic "reader" proteins in cancer and their alternative splicing mechanisms. Specifically, the paper aims to address the following key issues: 1. **The relationship between alternative splicing and epigenetic readers**: - The paper discusses in detail how alternative splicing affects the function of epigenetic "reader" proteins. These proteins can recognize specific histone modifications and play a crucial role in gene expression regulation. 2. **The role of alternative splicing in cancer pathogenesis**: - The study points out that many epigenetic "reader" proteins have different splice variants (such as full-length and short forms), which play different roles in tumorigenesis and development. For example, some short forms of splice variants may have oncogenic effects, while full-length forms may have tumor-suppressive effects. 3. **The impact of alternative splicing on drug sensitivity and radiotherapy**: - The paper explores how alternative splicing affects the response of cancer cells to treatment, particularly the impact on drug sensitivity and the effectiveness of radiotherapy. 4. **The role of alternative splicing in other physiological processes**: - Besides cancer, the paper also discusses the importance of alternative splicing in other developmental processes, such as spermatogenesis and neural tube development. By comprehensively analyzing these aspects, the paper emphasizes the complexity of alternative splicing events in epigenetic "reader" proteins and proposes future research directions, including the development of precise therapeutic strategies targeting specific splice variants.

A–Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer

Epigenetics and alternative splicing in cancer: old enemies, new perspectives

Significance of Alternative Splicing in Cancer Cells.

Alternative splicing and cancer: a systematic review

Epigenetic Regulation of Alternative Splicing.

Roles and mechanisms of alternative splicing in cancer — implications for care

Genomics of alternative splicing: evolution, development and pathophysiology

Splicing Dysregulation in Cancer: from Mechanistic Understanding to a New Class of Therapeutic Targets

Targeting splicing factors for cancer therapy

Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes

Targeting splicing for hematological malignancies therapy

How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors

Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response

The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer

Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies

Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics

Mechanisms of non-coding RNA-modulated alternative splicing in cancer

RNA splicing dysregulation and the hallmarks of cancer

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Splicing factors: Insights into their regulatory network in alternative splicing in cancer